Pharmacological and toxicological studies in neurodegenerative diseases focus on developing and evaluating treatments that can slow or halt the progression of conditions like Alzheimer's, Parkinson's, and Huntington's disease. These studies aim to understand how drugs interact with the brain and nervous system, identifying potential side effects and therapeutic benefits. Research often involves both preclinical models and clinical trials to ensure the safety and efficacy of new treatments, ultimately aiming to improve the quality of life for patients.
11.1 Alzheimer's Disease and Pharmacotherapy
11.2 Parkinson's Disease and Pharmacotherapy
11.3 Multiple Sclerosis and Pharmacotherapy
11.4 Huntington's Disease and Pharmacotherapy
11.5 Toxicity in Neurodegenerative Treatments
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
